Drug Profile
SP 15028
Alternative Names: SP15028Latest Information Update: 28 Jan 2023
Price :
$50
*
At a glance
- Originator Spherium Biomed
- Class Neuroprotectants; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Muscular atrophy
Most Recent Events
- 28 Jan 2023 No recent reports of development identified for preclinical development in Muscle-wasting in Spain (Parenteral)
- 18 Jan 2021 Preclinical development is ongoing for Muscle-wasting in Spain (Spherium Biomed pipeline, January 2021)
- 28 Oct 2020 No recent reports of development identified for preclinical development in Muscle-wasting in Spain (Parenteral)